Reyne, Nicole
Boog, Bernadette
Cmielewski, Patricia
McCarron, Alexandra
Smith, Ronan
Rout-Pitt, Nathan
Eikelis, Nina
Nilsen, Kris
Finnie, John
Louise, Jennie
Parsons, David
Donnelley, Martin
Funding for this research was provided by:
Australia’s Economic Accelerator
Cystic Fibrosis Foundation
Medical Research Future Fund
Article History
Received: 15 September 2025
Accepted: 24 February 2026
First Online: 10 March 2026
Declarations
:
: Not applicable.
: Not applicable.
: MD and DP were involved in the research development and validation of the XV technology and have personally purchased shares in 4DMedical. NE and KN employed by 4DMedical.